LONA · LeonaBio, Inc.
$7.70
+0.03 (+0.39%)
At close · Sep 3
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based upon the Company’s current operating plan, it estimates that its $51.1 million of cash, cash equivalents and investments at June 30, 2026 may not be sufficient to fund its operating expenses and capital expenditure requirements through at least the next 12 months which raises substantial doubt as to our ability to continue as a going concern following the date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$71.70M
Shares
9.42M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | Representative | Buy ST · Athira Pharma, Inc. (ATHA) | — CL TRUST > LDJ FAM INV LLC > Parametric | $1K - $15K | 2023-01-20 | 39d |
| 2022-11-08 | Christopher L. Jacobs | Representative | Sell ST · Athira Pharma, Inc. (ATHA) | — CL TRUST > LDJ FAM INV LLC > Parametric | $1K - $15K | 2022-12-12 | 34d |
| 2022-07-18 | Christopher L. Jacobs | Representative | Buy ST · Athira Pharma, Inc. (ATHA) | — CL TRUST > LDJ FAM INV LLC > Parametric | $1K - $15K | 2022-09-09 | 53d late |
Showing 1–3 of 3 trades
Key facts
CIK
1620463
CUSIP
04746L203
13F (30d)
44 filings
43 filers
Visit website
Investor relations